메뉴 건너뛰기




Volumn 5, Issue 1, 2007, Pages 55-66

HDL elevators and mimetrics - Emerging therapies for atherosclerosis

Author keywords

ApoA I; peroxisome proliferator activated receptors; Coronary heart disease (CHD); LXR Ligands; Reverse cholesterol transport (RCT); VLDL

Indexed keywords

1,13 DIHYDROXY 2,2,12,12 TETRAMETHYLTRIDECAN 7 ONE; 3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; ALPHA PHENOXYPHENYLPROPANOIC ACID; APOLIPOPROTEIN A1; AVP 26452; AZD 2479; BEZAFIBRATE; CHOLESTEROL ESTER TRANSFER PROTEIN; CLOFIBRATE; D 4F; DRF 10945; ESP 31015; ETC 1001; ETC 216; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GW 7647; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIGAND; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LY 518674; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; N OLEOYLETHANOLAMINE; NICOTINIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIRINIXIC ACID; PLACEBO; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG; ABC TRANSPORTER; ABC TRANSPORTER A1; CETP PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

EID: 33846057431     PISSN: 18715257     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152507779315796     Document Type: Review
Times cited : (31)

References (101)
  • 48
    • 33846055896 scopus 로고    scopus 로고
    • DailyDrugNews.com (Daily Essentials)
    • DailyDrugNews.com (Daily Essentials), 2004.
    • (2004)
  • 51
    • 85018893472 scopus 로고    scopus 로고
    • Ketone compounds and compositions for cholesterol management and related uses
    • U.S. Patent Application 20,030,078,239, October 11
    • Dasseux, J.-L.H.; Oniciu, D.C. Ketone compounds and compositions for cholesterol management and related uses. U.S. Patent Application 20,030,078,239, October 11, 2001.
    • (2001)
    • Dasseux, J.-L.H.1    Oniciu, D.C.2
  • 58
    • 0000680876 scopus 로고    scopus 로고
    • The Nuclear Receptors Nomenclature Committee
    • The Nuclear Receptors Nomenclature Committee. Cell, 1999, 97, 161.
    • (1999) Cell , vol.97 , pp. 161
  • 92
    • 33846111959 scopus 로고    scopus 로고
    • Substituted Tetrahydronaphthaline and Analogus Compounds
    • US6586613
    • Substituted Tetrahydronaphthaline and Analogus Compounds. US6586613, 2003.
    • (2003)
  • 93
    • 0006943112 scopus 로고    scopus 로고
    • Preparation of N-(1-Alkoxycarbonyl-1,2,3,4-Tetrahydroquinolin-4-yl)Carbamates as Cholesteryl Ester Transfer Protein Inhibitors
    • WO0017164
    • Deninno, M.P.; Mangus-Aryitey, G.T.; Ruggeri, R.B.; Wester, R.T. Preparation of N-(1-Alkoxycarbonyl-1,2,3,4-Tetrahydroquinolin-4-yl)Carbamates as Cholesteryl Ester Transfer Protein Inhibitors. WO0017164, 2000.
    • (2000)
    • Deninno, M.P.1    Mangus-Aryitey, G.T.2    Ruggeri, R.B.3    Wester, R.T.4
  • 94
    • 0003373144 scopus 로고    scopus 로고
    • Preparation of 4-Amino Substituted 2-Substituted 1,2,3,4-Tetrahydroquinolines as CETP Inhibitors
    • WO0017165
    • Deninno, M.P.; Mangus-Aryitey, G.T.; Ruggeri, R.B.; Wester, R.T. Preparation of 4-Amino Substituted 2-Substituted 1,2,3,4-Tetrahydroquinolines as CETP Inhibitors. WO0017165, 2000.
    • (2000)
    • Deninno, M.P.1    Mangus-Aryitey, G.T.2    Ruggeri, R.B.3    Wester, R.T.4
  • 95
    • 33846114117 scopus 로고    scopus 로고
    • Preparation of (2R,4S)-4-[(3,5-bistrifluoromethylbenzyl)-methoxycarbonylamino] -2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester as CETP inhibitor
    • WO0140190
    • Allen, D.J.M.; Appleton, T.A.; Brostrom, L.R.; Tickner, D.L. Preparation of (2R,4S)-4-[(3,5-bistrifluoromethylbenzyl)-methoxycarbonylamino] -2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester as CETP inhibitor. WO0140190, 2001.
    • (2001)
    • Allen, D.J.M.1    Appleton, T.A.2    Brostrom, L.R.3    Tickner, D.L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.